About the Journal

About the Journal

The "Journal of Advancement in Preclinical and Paraclinical Research (JAPPR)" is an official publication dedicated to the fields of preclinical and paraclinical sciences. Launched in July 2024, this journal provides a platform for peer-reviewed medical research. Adhering to open access policies, JAPPR ensures that articles are accessible to all readers at no cost. Additionally, the journal does not impose any fees for the submission, processing, or publication of manuscripts.

 Aims and Scope

JAPPR focuses on technical and clinical studies pertinent to health, ethical, and social issues within the realm of medical sciences. The journal prioritizes articles presenting original research and comprehensive reviews.

 Audience

The journal caters to an audience that includes readers and practitioners in medical sciences, emphasizing experimentation, observation, theoretical knowledge, and practical application.

 Review Process

JAPPR employs a stringent peer-review process to guarantee that manuscripts are scientifically sound, relevant, innovative, and significant. Authors are required to disclose all potential conflicts, affiliations, and financial associations to prevent bias in published content.

 Editorial Team

The editorial board of JAPPR consists of experts from various medical and allied sciences disciplines. These professionals offer their expertise and guidance to maintain the journal's clarity and focus.

 Journal Facts

JAPPR is an international peer-reviewed journal utilizing a double-blind review process. It publishes articles monthly once they pass peer review. The journal is available exclusively online, with articles provided in PDF format.

 Benefits

Articles published in JAPPR are accessible globally at no cost, enhancing the authors' visibility and recognition in the medical research community.

 Journal Ethics

JAPPR adheres to high ethical standards at all stages of publication, following guidelines from the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME). Specific policies regarding duplicate publication, conflicts of interest, and patient consent are strictly followed.

 Plagiarism Policy

JAPPR utilizes plagiarism detection software within its manuscript management system to ensure originality. Any manuscript found to contain plagiarism is rejected.

 Open Access and Licensing

JAPPR is an open access journal, with articles distributed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (CC-BY-NC-SA 4.0). This license allows non-commercial remixing, tweaking, and building upon the work, provided proper credit is given and new creations are licensed under identical terms.

 Ahead of Print Policy

Articles published online under the Online First model are considered published and can be cited using the DOI. No changes are made after publication, and articles are included in forthcoming issues based on their online first date.

 Scope of the Journal

JAPPR is an independent, authoritative source for advancing medical thought and research across various medical science disciplines. The journal publishes original research articles, reviews, commentaries, letters to the editor, case reports, and more. For detailed submission guidelines, please refer to the Guidelines for Authors. The mission of JAPPR is to disseminate knowledge, inspire reflection, and stimulate minds in the pursuit of medical excellence.